Clinical Trial Update: NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation [Phase 3]

View source ↗

Summary

Phase 3 trial update for NRX-101 as maintenance treatment in severe bipolar depression with suicidal ideation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression
• Bipolar Disorder
• Suicidal Ideation

Drugs mentioned

• NRX-101 (dextromethorphan/quinidine)

Snippet

Sponsor: NeuroRx, Inc. | Conditions: Bipolar Depression, Suicidal Ideation | Phase 3 | Status: UNKNOWN